| Anaphylaxis |
1 |
1 |
| Pharmacokinetics |
0 |
0.53 |
| Otolaryngology |
0 |
0.49 |
| Pharmacodynamics |
0 |
0.47 |
| France |
0 |
0.41 |
| Allergic Rhinitis |
0 |
0.3 |
| Blood |
0 |
0.29 |
| Europe |
0 |
0.29 |
| Obesity |
0 |
0.24 |
| Heart |
0 |
0.23 |
| Allergens |
0 |
0.18 |
| Plasma |
0 |
0.18 |
| Seasonal Allergic Rhinitis |
0 |
0.13 |
| Adverse Effects |
0 |
0.12 |
| Asthma |
0 |
0.12 |
| Body Mass Index |
0 |
0.12 |
| Caregiver |
0 |
0.12 |
| Child |
0 |
0.12 |
| Muscle |
0 |
0.12 |
| Rhinitis |
0 |
0.12 |
| Ultrasonography |
0 |
0.12 |
| Patient Safety |
0 |
0.1 |
| Food Allergy |
0 |
0.07 |
| Allergy |
0 |
0.06 |
| Anaplastic Lymphoma Kinase |
0 |
0.06 |
| Artificial Intelligence |
0 |
0.06 |
| Bronchospasm |
0 |
0.06 |
| Edema |
0 |
0.06 |
| Femoral |
0 |
0.06 |
| Finger |
0 |
0.06 |
| Health Education and Counseling |
0 |
0.06 |
| Hypotension |
0 |
0.06 |
| Immediate Hypersensitivity Reaction |
0 |
0.06 |
| Larynx |
0 |
0.06 |
| Metabolism |
0 |
0.06 |
| Nasal Cavity |
0 |
0.06 |
| Patient History |
0 |
0.06 |
| Phobia |
0 |
0.06 |
| Tissue |
0 |
0.06 |
| Tolerance |
0 |
0.06 |